The Valley Desk

ArticleNeuro-oncologyPublished

Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high-grade glioma models

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Neuro-oncology
Published
Subject terms
T-Lymphocytes; Tumor Cells, Cultured; Animals; Humans; Mice; Glioma; Brain Neoplasms; Gangliosides; RNA, Messenger; Immunotherapy, Adoptive; Xenograft Model Antitumor Assays; Female
PubMed ID
40411488
PubMed Central ID
PMC12833531
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal